AlzChem Group Valuation
| ACT Stock | EUR 57.40 0.20 0.35% |
At this time, the firm appears to be fairly valued. AlzChem Group AG shows a prevailing Real Value of €58.3 per share. The current price of the firm is €57.4. Our model approximates the value of AlzChem Group AG from analyzing the firm fundamentals such as EBITDA of 62.69 M, price to sales of 0.37 X, and Current Valuation of 261.71 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that AlzChem Group's price fluctuation is very steady at this time. Calculation of the real value of AlzChem Group AG is based on 3 months time horizon. Increasing AlzChem Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
AlzChem Group's intrinsic value may or may not be the same as its current market price of 57.40, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 57.4 | Real 58.3 | Hype 57.4 |
The intrinsic value of AlzChem Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence AlzChem Group's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of AlzChem Group AG helps investors to forecast how AlzChem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AlzChem Group more accurately as focusing exclusively on AlzChem Group's fundamentals will not take into account other important factors: AlzChem Group Total Value Analysis
AlzChem Group AG is presently anticipated to have takeover price of 261.71 M with market capitalization of 249.32 M, debt of 37.55 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AlzChem Group fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
261.71 M | 249.32 M | 37.55 M |
AlzChem Group Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of AlzChem implies not a very effective usage of assets in December.AlzChem Group Profitability Analysis
The company reported the revenue of 422.29 M. Net Income was 27.59 M with profit before overhead, payroll, taxes, and interest of 0.About AlzChem Group Valuation
The stock valuation mechanism determines AlzChem Group's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of AlzChem Group AG based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of AlzChem Group. We calculate exposure to AlzChem Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AlzChem Group's related companies.8 Steps to conduct AlzChem Group's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AlzChem Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AlzChem Group's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AlzChem Group's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AlzChem Group's revenue streams: Identify AlzChem Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AlzChem Group's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AlzChem Group's growth potential: Evaluate AlzChem Group's management, business model, and growth potential.
- Determine AlzChem Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AlzChem Group's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for AlzChem Stock Analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.